SCYNEXIS, Inc. Common Stock SCYX
i
Market dataready · fetched 2026-11-04T08:57:31.102Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-12-18
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-03T21:00:00.419925797Z
FundamentalsSEC EDGAR · ready · as of 2026-06-30 · fetched 2026-11-04T08:54:01.720258+00:00
SCYNEXIS, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 2.89 | 166.0% | 39.0% | |||
| 25Δ | 3.23 | 163.2% | 36.2% | |||
| 30Δ | 3.56 | 160.4% | 33.5% | |||
| 35Δ | 3.90 | 157.6% | 30.7% | |||
| 40Δ | 4.24 | 154.8% | 27.9% | |||
| 45Δ | 4.57 | 152.0% | 25.2% | |||
| 50Δ | 4.91 | 149.2% | 22.4% | |||
| 55Δ | 5.24 | 146.4% | 19.6% | |||
| 60Δ | 5.58 | 143.7% | 16.9% | |||
| 65Δ | 5.91 | 140.9% | 14.1% | |||
| 70Δ | 6.25 | 138.1% | 11.3% | |||
| 75Δ | 6.58 | 135.3% | 8.6% | |||
| 80Δ | 2.69 | 347.0% | 23.8% | 6.92 | 132.5% | 5.8% |
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.89
- IV
- 166.0%
- B/E move
- 39.0%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 3.23
- IV
- 163.2%
- B/E move
- 36.2%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 3.56
- IV
- 160.4%
- B/E move
- 33.5%
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 3.90
- IV
- 157.6%
- B/E move
- 30.7%
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 4.24
- IV
- 154.8%
- B/E move
- 27.9%
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 4.57
- IV
- 152.0%
- B/E move
- 25.2%
50Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 4.91
- IV
- 149.2%
- B/E move
- 22.4%
55Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 5.24
- IV
- 146.4%
- B/E move
- 19.6%
60Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 5.58
- IV
- 143.7%
- B/E move
- 16.9%
65Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 5.91
- IV
- 140.9%
- B/E move
- 14.1%
70Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 6.25
- IV
- 138.1%
- B/E move
- 11.3%
75Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 6.58
- IV
- 135.3%
- B/E move
- 8.6%
80Δ
- Pseudo strike
- 2.69
- IV
- 347.0%
- B/E move
- 23.8%
- Pseudo strike
- 6.92
- IV
- 132.5%
- B/E move
- 5.8%
Options history
No recorded observations
Drug Manufacturers - Specialty & Generic
SIGA
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health safety and infectious disease markets in the United States. The company is headquartered…
More →SUPN
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of diseases of the central nervous…
More →TAK
Takeda Pharmaceutical Company Limited is engaged in the research, development, manufacture and marketing of pharmaceuticals, over-the-counter drugs and quasi-drug consumer…
More →TEVA
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic drugs, specialty drugs, and biopharmaceuticals in North…
More →TKNO
Description unavailable
More →TLPH
Description unavailable
More →